BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352-362. [PMID: 18472213 DOI: 10.1016/j.canlet.2008.03.053] [Cited by in Crossref: 229] [Cited by in F6Publishing: 210] [Article Influence: 16.4] [Reference Citation Analysis]
Number Citing Articles
1 Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D, Jeandet P. Mechanistic Insights into the Pharmacological Significance of Silymarin. Molecules 2022;27:5327. [PMID: 36014565 DOI: 10.3390/molecules27165327] [Reference Citation Analysis]
2 Kirdeeva Y, Fedorova O, Daks A, Barlev N, Shuvalov O. How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology? Pharmaceuticals 2022;15:868. [DOI: 10.3390/ph15070868] [Reference Citation Analysis]
3 Yaghoubian I, Antar M, Ghassemi S, Modarres-Sanavy SAM, Smith DL. The Effects of Hydro-Priming and Colonization with Piriformospora indica and Azotobacter chroococcum on Physio-Biochemical Traits, Flavonolignans and Fatty Acids Composition of Milk Thistle (Silybum marianum) under Saline Conditions. Plants (Basel) 2022;11:1281. [PMID: 35631705 DOI: 10.3390/plants11101281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Melim C, Magalhães M, Santos AC, Campos EJ, Cabral C. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. Expert Opin Drug Deliv 2022. [PMID: 35166619 DOI: 10.1080/17425247.2022.2041599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Jia C, Zhang Z, Wang J, Nie Z. Silymarin protects the rats against paraquat-induced acute kidney injury via Nrf2. Hum Exp Toxicol 2022;41:9603271221074334. [PMID: 35128959 DOI: 10.1177/09603271221074334] [Reference Citation Analysis]
6 Sekar P, Ravitchandirane R, Khanam S, Muniraj N, Cassinadane AV. Novel molecules as the emerging trends in cancer treatment: an update. Med Oncol 2022;39:20. [PMID: 34982273 DOI: 10.1007/s12032-021-01615-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zahra N, Wahid A, Hafeez MB, Alyemeni MN, Shah T, Ahmad P. Plant growth promoters mediated quality and yield attributes of milk thistle (Silybum marianum L.) ecotypes under salinity stress. Sci Rep 2021;11:23200. [PMID: 34853350 DOI: 10.1038/s41598-021-02435-4] [Reference Citation Analysis]
8 Chun KS, Kim DH, Raut PK, Surh YJ. Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 2021:S1044-579X(21)00279-0. [PMID: 34838956 DOI: 10.1016/j.semcancer.2021.11.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zivarpour P, Hallajzadeh J, Asemi Z, Sadoughi F, Sharifi M. Chitosan as possible inhibitory agents and delivery systems in leukemia. Cancer Cell Int 2021;21:544. [PMID: 34663339 DOI: 10.1186/s12935-021-02243-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Bilgic E, Tuncel N, Koca T. Radio-sensitivity on MCF-7 cells of silver nanoparticles synthesized by Silybum marianum. Inorganic and Nano-Metal Chemistry. [DOI: 10.1080/24701556.2021.1987460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Addeo R. Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer. J Exp Pharmacol 2021;13:901-3. [PMID: 34611448 DOI: 10.2147/JEP.S326871] [Reference Citation Analysis]
13 Cho K, Lee HG, Piao JY, Kim SJ, Na HK, Surh YJ. Protective Effects of Silibinin on Helicobacter pylori-induced Gastritis: NF-κB and STAT3 as Potential Targets. J Cancer Prev 2021;26:118-27. [PMID: 34258250 DOI: 10.15430/JCP.2021.26.2.118] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Binienda A, Ziolkowska S, Pluciennik E. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer. Anticancer Agents Med Chem 2020;20:1787-96. [PMID: 31858905 DOI: 10.2174/1871520620666191220142741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Antal DS, Ardelean F, Avram S, Pavel IZ, Danciu C, Soica C, Dehelean C. Flavonolignans: One Step Further in the Broad-Spectrum Approach of Cancer. Anticancer Agents Med Chem 2020;20:1817-30. [PMID: 31976848 DOI: 10.2174/1871520620666200124112649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kollareddy M, Martinez LA. Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line. Cells 2021;10:797. [PMID: 33918387 DOI: 10.3390/cells10040797] [Reference Citation Analysis]
17 Faisal Z, Mohos V, Fliszár-Nyúl E, Valentová K, Káňová K, Lemli B, Kunsági-Máté S, Poór M. Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes. Biomed Pharmacother 2021;138:111459. [PMID: 33706132 DOI: 10.1016/j.biopha.2021.111459] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Garcia-Oliveira P, Otero P, Pereira AG, Chamorro F, Carpena M, Echave J, Fraga-Corral M, Simal-Gandara J, Prieto MA. Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment. Pharmaceuticals (Basel) 2021;14:157. [PMID: 33673021 DOI: 10.3390/ph14020157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
19 Divella R, Daniele A, Savino E, Paradiso A. Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model. Cancer Genomics Proteomics 2020;17:335-50. [PMID: 32576579 DOI: 10.21873/cgp.20193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
20 Chen X, Deng X, Han X, Liang Y, Meng Z, Liu R, Su W, Zhu H, Fu T. Inhibition of Lysozyme Amyloid Fibrillation by Silybin Diastereoisomers: The Effects of Stereochemistry. ACS Omega 2021;6:3307-18. [PMID: 33553948 DOI: 10.1021/acsomega.0c05788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Ghalehkhondabi V, Soleymani M, Fazlali A. Folate-targeted nanomicelles containing silibinin as an active drug delivery system for liver cancer therapy. Journal of Drug Delivery Science and Technology 2021;61:102157. [DOI: 10.1016/j.jddst.2020.102157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
22 Solé-Martí X, Espona-Noguera A, Ginebra MP, Canal C. Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions. Cancers (Basel) 2021;13:452. [PMID: 33504064 DOI: 10.3390/cancers13030452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Singh A, Singh DK, Kharwar RN, White JF, Gond SK. Fungal Endophytes as Efficient Sources of Plant-Derived Bioactive Compounds and Their Prospective Applications in Natural Product Drug Discovery: Insights, Avenues, and Challenges. Microorganisms 2021;9:197. [PMID: 33477910 DOI: 10.3390/microorganisms9010197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
24 Kaipa JM, Starkuviene V, Erfle H, Eils R, Gladilin E. Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells. PeerJ 2020;8:e10373. [PMID: 33362957 DOI: 10.7717/peerj.10373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Upadhyay P, Bhattacharjee M, Bhattacharya S, Ahir M, Adhikary A, Patra P. Silymarin-Loaded, Lactobionic Acid-Conjugated Porous PLGA Nanoparticles Induce Apoptosis in Liver Cancer Cells. ACS Appl Bio Mater 2020;3:7178-92. [PMID: 35019376 DOI: 10.1021/acsabm.0c00987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Mahdavi A, Bagherniya M, Fakheran O, Reiner Ž, Xu S, Sahebkar A. Medicinal plants and bioactive natural compounds as inhibitors of HMG-CoA reductase: A literature review. Biofactors 2020;46:906-26. [PMID: 33053603 DOI: 10.1002/biof.1684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
27 Ahmed LA, Abd El-Rhman RH, Gad AM, Hassaneen SK, El-Yamany MF. Dibenzazepine combats acute liver injury in rats via amendments of Notch signaling and activation of autophagy. Naunyn Schmiedebergs Arch Pharmacol 2021;394:337-48. [PMID: 32984915 DOI: 10.1007/s00210-020-01977-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Zhang J, Duan D, Song ZL, Liu T, Hou Y, Fang J. Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Med Res Rev 2021;41:342-94. [PMID: 32981100 DOI: 10.1002/med.21734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
29 Lazzeroni M, Petrangolini G, Legarreta Iriberri JA, Pascual Avellana J, Tost Robusté D, Cagnacci S, Macis D, Aristarco V, Bonanni B, Morazzoni P, Johansson H, Riva A. Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue. Molecules 2020;25:E2918. [PMID: 32599946 DOI: 10.3390/molecules25122918] [Reference Citation Analysis]
30 Estaji A, Niknam F. Foliar salicylic acid spraying effect’ on growth, seed oil content, and physiology of drought-stressed Silybum marianum L. plant. Agricultural Water Management 2020;234:106116. [DOI: 10.1016/j.agwat.2020.106116] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
31 Rezaee-tazangi F, Varaa N, Khorsandi L, Abbaspour M. Effects of Silymarin-Loaded Polylactic-co-Glycolic Acid Nanoparticles on Osteoarthritis in Rats. Iran J Sci Technol Trans Sci 2020;44:605-14. [DOI: 10.1007/s40995-020-00870-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Hrčková G, Kubašková TM, Mudroňová D, Bardelčíková A. Concentration-dependent effect of silymarin on concanavalin A-stimulated mouse spleen cells in vitro. European Pharmaceutical Journal 2020;0. [DOI: 10.2478/afpuc-2020-0003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Rodrigues DF, Pires das Neves R, Carvalho ATP, Lourdes Bastos M, Costa VM, Carvalho F. In vitro mechanistic studies on α-amanitin and its putative antidotes. Arch Toxicol 2020;94:2061-78. [PMID: 32193566 DOI: 10.1007/s00204-020-02718-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
34 Adhikari M, Adhikari B, Ghimire B, Baboota S, Choi EH. Cold Atmospheric Plasma and Silymarin Nanoemulsion Activate Autophagy in Human Melanoma Cells. Int J Mol Sci 2020;21:E1939. [PMID: 32178401 DOI: 10.3390/ijms21061939] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
35 Lee B, Choi GM, Sur B. Silibinin prevents depression-like behaviors in a single prolonged stress rat model: the possible role of serotonin. BMC Complement Med Ther 2020;20:70. [PMID: 32143600 DOI: 10.1186/s12906-020-2868-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
36 Camini FC, Costa DC. Silymarin: not just another antioxidant. Journal of Basic and Clinical Physiology and Pharmacology 2020;31. [DOI: 10.1515/jbcpp-2019-0206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
37 Kacar S, Bektur Aykanat NE, Sahinturk V. Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4. Med Oncol 2020;37. [DOI: 10.1007/s12032-020-1343-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ashraf MA. Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature's Bounty. Biomed Res Int 2020;2020:8602879. [PMID: 32076618 DOI: 10.1155/2020/8602879] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 11.0] [Reference Citation Analysis]
39 Bortlíková V, Kolarič L, Šimko P. Application of milk thistle ( Silybum marianum ) in functional biscuits formulation. Acta Chimica Slovaca 2019;12:192-9. [DOI: 10.2478/acs-2019-0027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Choe U, Li Y, Gao B, Yu L, Wang TTY, Sun J, Chen P, Yu LL. The chemical composition of a cold-pressed milk thistle seed flour extract, and its potential health beneficial properties. Food Funct 2019;10:2461-70. [PMID: 30977500 DOI: 10.1039/c9fo00377k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
41 Alipour M, Bigdeli M, Aligholi H, Rasoulian B, Khaksarian M. Sustained release of silibinin‐loaded chitosan nanoparticle induced apoptosis in glioma cells. J Biomed Mater Res 2020;108:458-69. [DOI: 10.1002/jbm.a.36827] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
42 Hassankhani Rad A, Asiaee F, Jafari S, Shayanfar A, Lavasanifar A, Molavi O. Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin. Bioimpacts 2020;10:87-95. [PMID: 32363152 DOI: 10.34172/bi.2020.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
43 Sharifi-Rad J, Ozleyen A, Boyunegmez Tumer T, Oluwaseun Adetunji C, El Omari N, Balahbib A, Taheri Y, Bouyahya A, Martorell M, Martins N, Cho WC. Natural Products and Synthetic Analogs as a Source of Antitumor Drugs. Biomolecules 2019;9:E679. [PMID: 31683894 DOI: 10.3390/biom9110679] [Cited by in Crossref: 32] [Cited by in F6Publishing: 55] [Article Influence: 10.7] [Reference Citation Analysis]
44 Takke A, Shende P. Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine: Nanotechnology, Biology and Medicine 2019;21:102057. [DOI: 10.1016/j.nano.2019.102057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
45 Rigon C, Marchiori MCL, da Silva Jardim F, Pegoraro NS, Chaves PDS, Velho MC, Beck RCR, Ourique AF, Sari MHM, Oliveira SMD, Cruz L. Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice. European Journal of Pharmaceutical Sciences 2019;137:104969. [DOI: 10.1016/j.ejps.2019.104969] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
46 Kim SH, Choo GS, Yoo ES, Woo JS, Han SH, Lee JH, Jung JY. Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells. Oncol Rep 2019;42:1904-14. [PMID: 31485597 DOI: 10.3892/or.2019.7295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hosseinabadi T, Lorigooini Z, Tabarzad M, Salehi B, Rodrigues CF, Martins N, Sharifi‐rad J. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer. Phytotherapy Research 2019;33:2849-61. [DOI: 10.1002/ptr.6470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
48 Pop S, Enciu AM, Tarcomnicu I, Gille E, Tanase C. Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation. Phytochem Rev 2019;18:1005-24. [DOI: 10.1007/s11101-019-09627-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
49 Zappavigna S, Vanacore D, Lama S, Potenza N, Russo A, Ferranti P, Dallio M, Federico A, Loguercio C, Sperlongano P, Caraglia M, Stiuso P. Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells. Int J Mol Sci 2019;20:E2190. [PMID: 31058823 DOI: 10.3390/ijms20092190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
50 Frank D, Indermun S, Govender M, Kumar P, Choonara YE, du Toit LC, Pillay V. Antineoplastic nano-lipobubbles for passively targeted ovarian cancer therapy. Colloids and Surfaces B: Biointerfaces 2019;177:160-8. [DOI: 10.1016/j.colsurfb.2019.01.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Wang J, Zhou H, Wang X, Mai K, He G. Effects of silymarin on growth performance, antioxidant capacity and immune response in turbot ( Scophthalmus maximus L.). J World Aquacult Soc 2019;50:1168-81. [DOI: 10.1111/jwas.12614] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
52 Kunnumakkara AB, Bordoloi D, Sailo BL, Roy NK, Thakur KK, Banik K, Shakibaei M, Gupta SC, Aggarwal BB. Cancer drug development: The missing links. Exp Biol Med (Maywood) 2019;244:663-89. [PMID: 30961357 DOI: 10.1177/1535370219839163] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
53 Mohammad IS, Hu H, Yin L, He W. Drug nanocrystals: Fabrication methods and promising therapeutic applications. Int J Pharm 2019;562:187-202. [PMID: 30851386 DOI: 10.1016/j.ijpharm.2019.02.045] [Cited by in Crossref: 41] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
54 Liu Y, Wang Y, Zhao J. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals. International Journal of Biological Macromolecules 2019;124:667-80. [DOI: 10.1016/j.ijbiomac.2018.11.258] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
55 Doğan Şiğva ZÖ, Balci Okcanoğlu T, Biray Avci Ç, Yilmaz Süslüer S, Kayabaşi Ç, Turna B, Dodurga Y, Nazli O, Gündüz C. Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines. Gene 2019;687:261-71. [DOI: 10.1016/j.gene.2018.11.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
56 Li W, Zhao X, Lv X, Han W, Wang H. Silibinin Retards Colitis-associated Carcinogenesis by Repression of Cdc25C in Mouse Model. Inflammatory Bowel Diseases 2019;25:1187-95. [DOI: 10.1093/ibd/izz007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
57 Abu-Serie MM, Habashy NH. Two purified proteins from royal jelly with in vitro dual anti-hepatic damage potency: Major royal jelly protein 2 and its novel isoform X1. Int J Biol Macromol 2019;128:782-95. [PMID: 30711561 DOI: 10.1016/j.ijbiomac.2019.01.210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
58 Yakovenko A, Cameron M, Trevino JG. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia. World J Gastrointest Surg 2018; 10(9): 95-106 [PMID: 30622678 DOI: 10.4240/wjgs.v10.i9.95] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
59 Nahari E, Razi M. Silymarin amplifies apoptosis in ectopic endometrial tissue in rats with endometriosis; implication on growth factor GDNF, ERK1/2 and Bcl-6b expression. Acta Histochem 2018;120:757-67. [PMID: 30195499 DOI: 10.1016/j.acthis.2018.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
60 Feldman NB, Gromovykh TI, Sedyakina NE, Krasnyuk II, Lutsenko SV. Cytotoxic and Antitumor Activity of Liposomal Silibinin. BioNanoSci 2018;8:971-6. [DOI: 10.1007/s12668-018-0556-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Ijaz S, Akhtar N, Khan MS, Hameed A, Irfan M, Arshad MA, Ali S, Asrar M. Plant derived anticancer agents: A green approach towards skin cancers. Biomedicine & Pharmacotherapy 2018;103:1643-51. [DOI: 10.1016/j.biopha.2018.04.113] [Cited by in Crossref: 32] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
62 Chassagne F, Haddad M, Amiel A, Phakeovilay C, Manithip C, Bourdy G, Deharo E, Marti G. A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases. Fitoterapia 2018;127:226-36. [DOI: 10.1016/j.fitote.2018.02.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
63 Amawi H, Hussein NA, Ashby CR Jr, Alnafisah R, Sanglard LM, Manivannan E, Karthikeyan C, Trivedi P, Eisenmann KM, Robey RW, Tiwari AK. Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis. Front Pharmacol 2018;9:520. [PMID: 29875662 DOI: 10.3389/fphar.2018.00520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
64 Mao J, Yang H, Cui T, Pan P, Kabir N, Chen D, Ma J, Chen X, Chen Y, Yang Y. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. Eur J Pharmacol 2018;832:39-49. [PMID: 29782854 DOI: 10.1016/j.ejphar.2018.05.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
65 Foulkes E, Newell-Price J. New Molecular Targets for Treatment of Cushing's Disease. Endocrinol Metab Clin North Am 2018;47:367-73. [PMID: 29754637 DOI: 10.1016/j.ecl.2018.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Won D, Kim L, Jang B, Yang I, Kwon H, Jin B, Oh SH, Kang J, Hong S, Shin J, Cho S. In vitro and in vivo anti-cancer activity of silymarin on oral cancer. Tumour Biol 2018;40:101042831877617. [DOI: 10.1177/1010428318776170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
67 Ullah H, Khan H. Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing. Front Pharmacol 2018;9:422. [PMID: 29755356 DOI: 10.3389/fphar.2018.00422] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
68 Safarpoor M, Ghaedi M, Asfaram A, Yousefi-nejad M, Javadian H, Zare Khafri H, Bagherinasab M. Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles. Ultrasonics Sonochemistry 2018;42:76-83. [DOI: 10.1016/j.ultsonch.2017.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
69 Prack Mc Cormick B, Langle Y, Belgorosky D, Vanzulli S, Balarino N, Sandes E, Eiján AM. Flavonoid silybin improves the response to radiotherapy in invasive bladder cancer. J Cell Biochem 2018;119:5402-12. [PMID: 29363820 DOI: 10.1002/jcb.26693] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
70 Zhang P, Hölscher C, Ma X. Therapeutic potential of flavonoids in spinal cord injury. Rev Neurosci 2017;28:87-101. [PMID: 28045676 DOI: 10.1515/revneuro-2016-0053] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
71 Bijak M, Synowiec E, Sitarek P, Sliwiński T, Saluk-Bijak J. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models. Nutrients 2017;9:E1356. [PMID: 29240674 DOI: 10.3390/nu9121356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
72 Cui H, Li TL, Guo HF, Wang JL, Xue P, Zhang Y, Fan JH, Li ZP, Gao YJ. Silymarin-mediated regulation of the cell cycle and DNA damage response exerts antitumor activity in human hepatocellular carcinoma. Oncol Lett 2018;15:885-92. [PMID: 29399153 DOI: 10.3892/ol.2017.7425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
73 Kuen CY, Fakurazi S, Othman SS, Masarudin MJ. Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems. Nanomaterials (Basel) 2017;7:E379. [PMID: 29117121 DOI: 10.3390/nano7110379] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
74 Zhu Z, Sun G. Silymarin mitigates lung impairments in a rat model of acute respiratory distress syndrome. Inflammopharmacol 2018;26:747-54. [DOI: 10.1007/s10787-017-0407-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
75 Bijak M, Dziedzic A, Synowiec E, Sliwinski T, Saluk-Bijak J. Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes. Nutrients 2017;9:E1022. [PMID: 28914761 DOI: 10.3390/nu9091022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
76 Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B. Silymarin impacts on immune system as an immunomodulator: One key for many locks. International Immunopharmacology 2017;50:194-201. [DOI: 10.1016/j.intimp.2017.06.030] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
77 Attia YA, Hamed RS, Bovera F, Abd El-hamid AEE, Al-harthi MA, Shahba HA. Semen quality, antioxidant status and reproductive performance of rabbits bucks fed milk thistle seeds and rosemary leaves. Animal Reproduction Science 2017;184:178-86. [DOI: 10.1016/j.anireprosci.2017.07.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
78 Belli V, Sforza V, Cardone C, Martinelli E, Barra G, Matrone N, Napolitano S, Morgillo F, Tuccillo C, Federico A, Dallio M, Loguercio C, Gravina AG, De Palma R, Ciardiello F, Troiani T. Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer. Oncotarget 2017;8:68305-16. [PMID: 28978118 DOI: 10.18632/oncotarget.20054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
79 de Avelar CR, Pereira EM, de Farias Costa PR, de Jesus RP, de Oliveira LPM. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J Gastroenterol 2017; 23(27): 5004-5017 [PMID: 28785154 DOI: 10.3748/wjg.v23.i27.5004] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
80 Chambers CS, Holečková V, Petrásková L, Biedermann D, Valentová K, Buchta M, Křen V. The silymarin composition… and why does it matter??? Food Res Int 2017;100:339-53. [PMID: 28964357 DOI: 10.1016/j.foodres.2017.07.017] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
81 Kandemir FM, Kucukler S, Caglayan C, Gur C, Batil AA, Gülçin İ. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: Biochemical evaluation of anti-inflammatory, antiapoptotic, and antiautophagic properties. J Food Biochem 2017;41:e12398. [DOI: 10.1111/jfbc.12398] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 10.6] [Reference Citation Analysis]
82 Dionisie V, Clichici S, Ion RM, Danila OO, Moldovan R, Decea N, Gheban D, Olteanu FC, Filip GA. In vivo silymarin’s antioxidant and anti-apoptotic effects on photodynamic therapy’s responsiveness. J Porphyrins Phthalocyanines 2017;21:189-97. [DOI: 10.1142/s1088424617500304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
83 Mouhid L, Corzo-Martínez M, Torres C, Vázquez L, Reglero G, Fornari T, Ramírez de Molina A. Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems. J Oncol 2017;2017:7351976. [PMID: 28555156 DOI: 10.1155/2017/7351976] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
84 Daniel E, Newell-Price J. Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations. F1000Res 2017;6:613. [PMID: 28529722 DOI: 10.12688/f1000research.10968.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
85 Qiu P, Dong Y, Li B, Kang XJ, Gu C, Zhu T, Luo YY, Pang MX, Du WF, Ge WH. Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1/Nrf2 pathway to alleviate ethanol-induced hepatic injury. Toxicol Lett. 2017;274:31-41. [PMID: 28419832 DOI: 10.1016/j.toxlet.2017.04.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
86 Choi ES, Oh S, Jang B, Yu HJ, Shin JA, Cho NP, Yang IH, Won DH, Kwon HJ, Hong SD, Cho SD. Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade. Cell Oncol (Dordr) 2017;40:235-46. [PMID: 28401485 DOI: 10.1007/s13402-017-0318-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
87 Chen CL, Chen JT, Liang CM, Tai MC, Lu DW, Chen YH. Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro. PLoS One 2017;12:e0174971. [PMID: 28376126 DOI: 10.1371/journal.pone.0174971] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
88 Srivastava S, Sammi SR, Laxman TS, Pant A, Nagar A, Trivedi S, Bhatta RS, Tandon S, Pandey R. Silymarin promotes longevity and alleviates Parkinson’s associated pathologies in Caenorhabditis elegans. Journal of Functional Foods 2017;31:32-43. [DOI: 10.1016/j.jff.2017.01.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
89 Manivannan E, Amawi H, Hussein N, Karthikeyan C, Fetcenko A, Narayana Moorthy NSH, Trivedi P, Tiwari AK. Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive - Based, natural product lead optimization approach. Eur J Med Chem 2017;133:365-78. [PMID: 28411546 DOI: 10.1016/j.ejmech.2017.03.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
90 Filippopoulou K, Papaevgeniou N, Lefaki M, Paraskevopoulou A, Biedermann D, Křen V, Chondrogianni N. 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radic Biol Med 2017;103:256-67. [PMID: 28039083 DOI: 10.1016/j.freeradbiomed.2016.12.042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
91 Chen YH, Chen CL, Lu DW, Liang CM, Tai MC, Chen JT. Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner. PLoS One 2016;11:e0168765. [PMID: 28030611 DOI: 10.1371/journal.pone.0168765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
92 Momtaz S, Niaz K, Maqbool F, Abdollahi M, Rastrelli L, Nabavi SM. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma: STAT3 targeting by polyphenols. BioFactors 2017;43:347-70. [DOI: 10.1002/biof.1345] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
93 Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review. European Journal of Medicinal Chemistry 2016;123:577-95. [DOI: 10.1016/j.ejmech.2016.07.070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
94 Rigby CM, Roy S, Deep G, Guillermo-Lagae R, Jain AK, Dhar D, Orlicky DJ, Agarwal C, Agarwal R. Role of p53 in silibinin-mediated inhibition of ultraviolet B radiation-induced DNA damage, inflammation and skin carcinogenesis. Carcinogenesis 2017;38:40-50. [PMID: 27729375 DOI: 10.1093/carcin/bgw106] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
95 Shukla SK, Dasgupta A, Mehla K, Gunda V, Vernucci E, Souchek J, Goode G, King R, Mishra A, Rai I. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015;6:41146-41161. [PMID: 26510913 DOI: 10.18632/oncotarget.5843] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
96 Shirali S, Shokri Mashhadi N, Ashtary-larky D, Safania T, Barari A. Effects of Silymarin Supplementation on Leptin, Adiponectin and Paraoxanase Levels and Body Composition During Exercise: A Randomized Double-Blind Placebo Controlled Clinical Trial. Jundishapur J Nat Pharm Prod 2016;11. [DOI: 10.17795/jjnpp-30044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
97 Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015;35 Suppl:S276-S304. [PMID: 26590477 DOI: 10.1016/j.semcancer.2015.09.007] [Cited by in Crossref: 148] [Cited by in F6Publishing: 160] [Article Influence: 24.7] [Reference Citation Analysis]
98 Hagag AA, Elgamsy MA, El-Asy HM, Mabrouk MM. Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia. Mediterr J Hematol Infect Dis 2016;8:e2016043. [PMID: 27648206 DOI: 10.4084/MJHID.2016.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
99 Yi T, Liu C, Zhang J, Wang F, Wang J, Zhang J. A new drug nanocrystal self-stabilized Pickering emulsion for oral delivery of silybin. Eur J Pharm Sci 2017;96:420-7. [PMID: 27575878 DOI: 10.1016/j.ejps.2016.08.047] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
100 Paul S, Arya A, Gangwar A, Bhargava K, Ahmad Y. Size restricted silymarin suspension evokes integrated adaptive response against acute hypoxia exposure in rat lung. Free Radical Biology and Medicine 2016;96:139-51. [DOI: 10.1016/j.freeradbiomed.2016.04.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
101 Borges FF, Silva CR, Véras JH, Cardoso CG, da Cruz AD, Chen LC. Antimutagenic, Antigenotoxic, and Anticytotoxic Activities of Silybum Marianum [L.] Gaertn Assessed by the Salmonella Mutagenicity Assay (Ames Test) and the Micronucleus Test in Mice Bone Marrow. Nutr Cancer 2016;68:848-55. [PMID: 27352027 DOI: 10.1080/01635581.2016.1180414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
102 Montgomery A, Adeyeni T, San K, Heuertz RM, Ezekiel UR. Curcumin Sensitizes Silymarin to Exert Synergistic Anticancer Activity in Colon Cancer Cells. J Cancer 2016;7:1250-7. [PMID: 27390600 DOI: 10.7150/jca.15690] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
103 Lucini L, Kane D, Pellizzoni M, Ferrari A, Trevisi E, Ruzickova G, Arslan D. Phenolic profile and in vitro antioxidant power of different milk thistle [Silybum marianum (L.) Gaertn.] cultivars. Industrial Crops and Products 2016;83:11-6. [DOI: 10.1016/j.indcrop.2015.12.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
104 Eo HJ, Park GH, Jeong JB. Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells. Biomol Ther (Seoul) 2016;24:380-6. [PMID: 27068260 DOI: 10.4062/biomolther.2015.154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
105 Darvishi Khezri H, Salehifar E, Kosaryan M, Aliasgharian A, Jalali H, Hadian Amree A. Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015. Adv Pharmacol Sci 2016;2016:3046373. [PMID: 26997953 DOI: 10.1155/2016/3046373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
106 Pereira A, Bester M, Soundy P, Apostolides Z. Anti-proliferative properties of commercial Pelargonium sidoides tincture, with cell-cycle G0/G1 arrest and apoptosis in Jurkat leukaemia cells. Pharm Biol 2016;54:1831-40. [PMID: 26794080 DOI: 10.3109/13880209.2015.1129545] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
107 Gohulkumar M, Kumar P, Murali Krishna C, Krishnakumar N. Evaluation of Raman spectroscopy for prediction of antitumor response to silibinin and its nanoparticulates in DMBA-induced oral carcinogenesis: Antitumor response to silibinin and its nanoparticulates. J Raman Spectrosc 2016;47:375-83. [DOI: 10.1002/jrs.4831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
108 Kim S, Kim K, Yu S, Park S, Choi H, Ji J, Ahn S. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells. Biochemical and Biophysical Research Communications 2015;468:151-6. [DOI: 10.1016/j.bbrc.2015.10.143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
109 Gufford BT, Barr JT, González-Pérez V, Layton ME, White JR Jr, Oberlies NH, Paine MF. Quantitative prediction and clinical evaluation of an unexplored herb-drug interaction mechanism in healthy volunteers. CPT Pharmacometrics Syst Pharmacol 2015;4:701-10. [PMID: 26904384 DOI: 10.1002/psp4.12047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
110 Vanajothi R, Srinivasan P. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway. J Recept Signal Transduct Res 2016;36:292-302. [PMID: 26585176 DOI: 10.3109/10799893.2015.1108335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
111 Raina K, Kumar S, Dhar D, Agarwal R. Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy. J Biomed Res 2016;30:452-65. [PMID: 27476880 DOI: 10.7555/JBR.30.20150111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
112 Han X, Wang Z, Wang M, Li J, Xu Y, He R, Guan H, Yue Z, Gong M. Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration. Drug Deliv 2016;23:1818-29. [PMID: 26556526 DOI: 10.3109/10717544.2015.1108374] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
113 Wu JP, Tsai CC, Yeh YL, Lin YM, Lin CC, Day CH, Shen CY, Padma VV, Pan LF, Huang CY. Silymarin Accelerates Liver Regeneration after Partial Hepatectomy. Evid Based Complement Alternat Med 2015;2015:603529. [PMID: 26339266 DOI: 10.1155/2015/603529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
114 Lovelace ES, Wagoner J, MacDonald J, Bammler T, Bruckner J, Brownell J, Beyer RP, Zink EM, Kim YM, Kyle JE, Webb-Robertson BJ, Waters KM, Metz TO, Farin F, Oberlies NH, Polyak SJ. Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling. J Nat Prod 2015;78:1990-2000. [PMID: 26186142 DOI: 10.1021/acs.jnatprod.5b00288] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
115 Son Y, Lee HJ, Rho JK, Chung SY, Lee CG, Yang K, Kim SH, Lee M, Shin IS, Kim JS. The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer. BMC Pulm Med 2015;15:68. [PMID: 26143275 DOI: 10.1186/s12890-015-0055-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
116 Gufford BT, Chen G, Vergara AG, Lazarus P, Oberlies NH, Paine MF. Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction. Drug Metab Dispos 2015;43:1353-9. [PMID: 26070840 DOI: 10.1124/dmd.115.065086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
117 Sun J, Li F, Zhao Y, Zhao L, Qiao C, Li Z, Guo Q, Lu N. LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-κB Signaling Pathway. PLoS One 2015;10:e0127282. [PMID: 26023926 DOI: 10.1371/journal.pone.0127282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
118 Lin X, Peng Z, Su C. Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone. Int J Mol Sci 2015;16:10888-906. [PMID: 25984608 DOI: 10.3390/ijms160510888] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
119 Kumar S, Raina K, Agarwal C, Agarwal R. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals. Oncotarget 2014;5:4972-89. [PMID: 24970802 DOI: 10.18632/oncotarget.2068] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
120 Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol (Praha) 2015;60:351-6. [PMID: 25937395 DOI: 10.1007/s12223-015-0399-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
121 Bosch-Barrera J, Menendez JA. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treat Rev. 2015;41:540-546. [PMID: 25944486 DOI: 10.1016/j.ctrv.2015.04.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
122 Surai PF. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants (Basel) 2015;4:204-47. [PMID: 26785346 DOI: 10.3390/antiox4010204] [Cited by in Crossref: 227] [Cited by in F6Publishing: 231] [Article Influence: 32.4] [Reference Citation Analysis]
123 Riebold M, Kozany C, Freiburger L, Sattler M, Buchfelder M, Hausch F, Stalla GK, Paez-Pereda M. A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. Nat Med 2015;21:276-80. [PMID: 25665180 DOI: 10.1038/nm.3776] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
124 Moayedi Esfahani BA, Reisi N, Mirmoghtadaei M. Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review. Hemoglobin 2015;39:75-80. [PMID: 25643967 DOI: 10.3109/03630269.2014.1003224] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
125 Eo HJ, Park GH, Song HM, Lee JW, Kim MK, Lee MH, Lee JR, Koo JS, Jeong JB. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. International Immunopharmacology 2015;24:1-6. [DOI: 10.1016/j.intimp.2014.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
126 Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J Gastroenterol 2014; 20(47): 17756-17772 [PMID: 25548474 DOI: 10.3748/wjg.v20.i47.17756] [Cited by in CrossRef: 234] [Cited by in F6Publishing: 205] [Article Influence: 29.3] [Reference Citation Analysis]
127 Tilley C, Deep G, Agarwal C, Wempe MF, Biedermann D, Valentová K, Kren V, Agarwal R. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol Carcinog 2016;55:3-14. [PMID: 25492239 DOI: 10.1002/mc.22253] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
128 Cho BO, So Y, Jin CH, Nam BM, Yee S, Jeong IY. 3-deoxysilybin exerts anti-inflammatory effects by suppressing NF-κB activation in lipopolysaccharide-stimulated RAW264.7 macrophages. Bioscience, Biotechnology, and Biochemistry 2014;78:2051-8. [DOI: 10.1080/09168451.2014.948377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
129 Fan L, Ma Y, Liu Y, Zheng D, Huang G. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. European Journal of Pharmacology 2014;743:79-88. [DOI: 10.1016/j.ejphar.2014.09.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
130 Nagarajan S, Namasivayam N. Silibinin alleviates hyperlipidaemia, restores mucin content, modulates TGF-β and fosters apoptosis in experimental rat colon carcinogenesis. Journal of Functional Foods 2014;11:472-81. [DOI: 10.1016/j.jff.2014.10.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
131 Ashkavand Z, Malekinejad H, Vishwanath B. Combined action of Silymarin and Celecoxib in modulating inflammatory mediators in osteoarthritis. Biomedicine & Preventive Nutrition 2014;4:485-90. [DOI: 10.1016/j.bionut.2014.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Pooja D, Babu Bikkina DJ, Kulhari H, Nikhila N, Chinde S, Raghavendra YM, Sreedhar B, Tiwari AK. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles. Int J Biol Macromol 2014;69:267-73. [PMID: 24863917 DOI: 10.1016/j.ijbiomac.2014.05.035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
133 Noori-daloii MR, Saffari M, Raoofian R, Yekaninejad M, Dinehkabodi OS, Noori-daloii AR. The multidrug resistance pumps are inhibited by silibinin and apoptosis induced in K562 and KCL22 leukemia cell lines. Leukemia Research 2014;38:575-80. [DOI: 10.1016/j.leukres.2013.10.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
134 Yurtcu E, İşeri Ö, Sahin F. Genotoxic and cytotoxic effects of doxorubicin and silymarin on human hepatocellular carcinoma cells. Hum Exp Toxicol 2014;33:1269-76. [PMID: 24677352 DOI: 10.1177/0960327114529453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
135 Gopalakrishnan R, Raghu K. Biosynthesis and Characterization of Gold and Silver Nanoparticles Using Milk Thistle ( Silybum marianum ) Seed Extract. Journal of Nanoscience 2014;2014:1-8. [DOI: 10.1155/2014/905404] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
136 Cho SI, Lee J, Do NY. Protective effect of silymarin against cisplatin-induced ototoxicity. International Journal of Pediatric Otorhinolaryngology 2014;78:474-8. [DOI: 10.1016/j.ijporl.2013.12.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
137 Woo SM, Min K, Kim S, Park J, Kim DE, Chun K, Kim YH, Lee T, Kim SH, Choi YH, Chang J, Kwon TK. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation. Chemico-Biological Interactions 2014;211:36-43. [DOI: 10.1016/j.cbi.2014.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
138 Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q, Su C. Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol. 2014;35:5111-5119. [PMID: 24526416 DOI: 10.1007/s13277-014-1680-z] [Cited by in Crossref: 127] [Cited by in F6Publishing: 132] [Article Influence: 15.9] [Reference Citation Analysis]
139 Grillo C, Chichiarelli S, Gaucci E, Altieri F, Turano C, Cervoni L. The binding of silibinin to ERp57. Chem Biol Interact 2014;213:37-43. [PMID: 24530445 DOI: 10.1016/j.cbi.2014.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
140 Cho BO, So Y, Jin CH, Byun MW, Seo KI, Ko K, Chun MS, Jeong IY. Induction of apoptosis by 2,3-dehydrosilybin via a caspase-dependent pathway in human HeLa cells. Bioscience, Biotechnology, and Biochemistry 2014;78:255-62. [DOI: 10.1080/09168451.2014.885828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
141 El-elimat T, Raja HA, Graf TN, Faeth SH, Cech NB, Oberlies NH. Flavonolignans from Aspergillus iizukae , a Fungal Endophyte of Milk Thistle ( Silybum marianum ). J Nat Prod 2014;77:193-9. [DOI: 10.1021/np400955q] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
142 Frank D, Tyagi C, Tomar L, Choonara YE, du Toit LC, Kumar P, Penny C, Pillay V. Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine 2014;9:589-613. [PMID: 24489467 DOI: 10.2147/IJN.S50941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
143 Forghani P, Khorramizadeh MR, Waller EK. Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer. Cancer Med 2014;3:215-24. [PMID: 24574320 DOI: 10.1002/cam4.186] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
144 Mateen S, Raina K, Agarwal R. Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer. Nutr Cancer. 2013;65:3-11. [PMID: 23682778 DOI: 10.1080/01635581.2013.785004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
145 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
146 Anthony KP, Saleh MA. Free Radical Scavenging and Antioxidant Activities of Silymarin Components. Antioxidants (Basel) 2013;2:398-407. [PMID: 26784472 DOI: 10.3390/antiox2040398] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
147 Gadad PC, Matthews KH, Knott RM. Silymarin released from sterile wafers restores glucose impaired endothelial cell migration. International Journal of Pharmaceutics 2013;457:40-9. [DOI: 10.1016/j.ijpharm.2013.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
148 Chen YH, Liang CM, Chen CL, Chen JT, Chang YH, Lu DW, Chien KH, Tai MC. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. Acta Ophthalmol 2013;91:e506-15. [PMID: 23764119 DOI: 10.1111/aos.12160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
149 Woo SM, Min K, Chae IG, Chun K, Kwon TK. Silymarin suppresses the PGE 2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways: SILYMARIN INHIBITS THE PGE 2 -INDUCED MIGRATION. Mol Carcinog 2015;54:216-28. [DOI: 10.1002/mc.22092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
150 Cacho M, Torres Domínguez A, Elena-rosselló J. Role of polyamines in regulating silymarin production in Silybum marianum (L.) Gaertn (Asteraceae) cell cultures under conditions of calcium deficiency. Journal of Plant Physiology 2013;170:1344-8. [DOI: 10.1016/j.jplph.2013.05.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
151 Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food. 2013;16:778-784. [PMID: 23909904 DOI: 10.1089/jmf.2012.2534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
152 Althagafy HS, Meza-Aviña ME, Oberlies NH, Croatt MP. Mechanistic study of the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle. J Org Chem 2013;78:7594-600. [PMID: 23876147 DOI: 10.1021/jo4011377] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
153 Sadava D, Kane SE. Silibinin reverses drug resistance in human small-cell lung carcinoma cells. Cancer Lett 2013;339:102-6. [PMID: 23879966 DOI: 10.1016/j.canlet.2013.07.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
154 Stephens L, Whitehouse J, Polley M. Western herbal medicine, epigenetics, and endometriosis. J Altern Complement Med 2013;19:853-9. [PMID: 23738681 DOI: 10.1089/acm.2012.0623] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
155 Raina K, Agarwal R. Promise and potential of silibinin in colorectal cancer management: what patterns can be seen? Future Oncol 2013;9:759-61. [PMID: 23718291 DOI: 10.2217/fon.13.51] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
156 Derry MM, Raina K, Agarwal C, Agarwal R. Identifying molecular targets of lifestyle modifications in colon cancer prevention. Front Oncol 2013;3:119. [PMID: 23675573 DOI: 10.3389/fonc.2013.00119] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
157 Cho HJ, Suh DS, Moon SH, Song YJ, Yoon MS, Park DY, Choi KU, Kim YK, Kim KH. Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells. J Agric Food Chem 2013;61:4089-96. [PMID: 23570653 DOI: 10.1021/jf400192v] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
158 Althagafy HS, Graf TN, Sy-Cordero AA, Gufford BT, Paine MF, Wagoner J, Polyak SJ, Croatt MP, Oberlies NH. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle. Bioorg Med Chem 2013;21:3919-26. [PMID: 23673225 DOI: 10.1016/j.bmc.2013.04.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
159 Theodosiou E, Purchartová K, Stamatis H, Kolisis F, Křen V. Bioavailability of silymarin flavonolignans: drug formulations and biotransformation. Phytochem Rev 2014;13:1-18. [DOI: 10.1007/s11101-013-9285-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
160 Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C. Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy? Free Radic Biol Med 2013;61:143-50. [PMID: 23548635 DOI: 10.1016/j.freeradbiomed.2013.03.019] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 6.7] [Reference Citation Analysis]
161 Napolitano JG, Lankin DC, Graf TN, Friesen JB, Chen SN, McAlpine JB, Oberlies NH, Pauli GF. HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin case. J Org Chem 2013;78:2827-39. [PMID: 23461697 DOI: 10.1021/jo302720h] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 8.1] [Reference Citation Analysis]
162 Polyak SJ, Ferenci P, Pawlotsky JM. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology 2013;57:1262-71. [PMID: 23213025 DOI: 10.1002/hep.26179] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 8.7] [Reference Citation Analysis]
163 Derry M, Raina K, Agarwal R, Agarwal C. Differential effects of grape seed extract against human colorectal cancer cell lines: the intricate role of death receptors and mitochondria. Cancer Lett 2013;334:69-78. [PMID: 23268334 DOI: 10.1016/j.canlet.2012.12.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
164 Cho BO, Ryu HW, So Y, Jin CH, Baek JY, Park KH, Byun EH, Jeong IY. Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats. Food Chem. 2013;138:107-115. [PMID: 23265463 DOI: 10.1016/j.foodchem.2012.10.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
165 Sy-Cordero AA, Day CS, Oberlies NH. Absolute configuration of isosilybin A by X-ray crystallography of the heavy atom analogue 7-(4-Bromobenzoyl)isosilybin A. J Nat Prod 2012;75:1879-81. [PMID: 23116206 DOI: 10.1021/np3005369] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
166 Polyak SJ, Oberlies NH, Pécheur EI, Dahari H, Ferenci P, Pawlotsky JM. Silymarin for HCV infection. Antivir Ther 2013;18:141-7. [PMID: 23011959 DOI: 10.3851/IMP2402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
167 Mateen S, Raina K, Jain AK, Agarwal C, Chan D, Agarwal R. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics 2012;7:1161-72. [PMID: 22965008 DOI: 10.4161/epi.22070] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
168 Anestopoulos I, Kavo A, Tentes I, Kortsaris A, Panayiotidis M, Lazou A, Pappa A. Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms. J Nutr Biochem 2013;24:586-94. [PMID: 22818713 DOI: 10.1016/j.jnutbio.2012.02.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
169 Hădărugă DI, Hădărugă NG, Bandur GN, Isengard H. Water content of flavonoid/cyclodextrin nanoparticles: Relationship with the structural descriptors of biologically active compounds. Food Chemistry 2012;132:1651-9. [DOI: 10.1016/j.foodchem.2011.06.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
170 Duffy R, Wade C, Chang R. Discovery of anticancer drugs from antimalarial natural products: a MEDLINE literature review. Drug Discov Today 2012;17:942-53. [PMID: 22504324 DOI: 10.1016/j.drudis.2012.03.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
171 Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C. Oxaliplatin-Induced Neuropathy: Oxidative Stress as Pathological Mechanism. Protective Effect of Silibinin. The Journal of Pain 2012;13:276-84. [DOI: 10.1016/j.jpain.2011.11.009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 116] [Article Influence: 10.3] [Reference Citation Analysis]
172 Yan X, Gardner TR, Grieco M, Herath SA, Jang JH, Kirchoff D, Njoh L, Shantha Kumara HM, Naffouje S, Whelan RL. Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models. Surg Endosc 2012;26:1856-64. [PMID: 22258296 DOI: 10.1007/s00464-011-2114-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
173 Agarwal A, Chakraborty P, Chakraborty DD, Saharan VA. Phytosomes: Complexation, Utilisation and Commerical Status. Journal of Biologically Active Products from Nature 2012;2:65-77. [DOI: 10.1080/22311866.2012.10719111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Mukherjee PK, Ponnusankar S, Venkatesh P, Gantait A, Pal BC. Marker Profiling: An Approach for Quality Evaluation of Indian Medicinal Plants. Drug Information J 2011;45:1-14. [DOI: 10.1177/009286151104500101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
175 Dastpeyman M, Motamed N, Azadmanesh K, Mostafavi E, Kia V, Jahanian-najafabadi A, Shokrgozar MA. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI. Med Oncol 2012;29:2512-8. [DOI: 10.1007/s12032-011-0113-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
176 El Mesallamy HO, Metwally NS, Soliman MS, Ahmed KA, Abdel Moaty MM. The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats. Cancer Cell Int. 2011;11:38. [PMID: 22040519 DOI: 10.1186/1475-2867-11-38] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
177 Dizaji MZ, Malehmir M, Ghavamzadeh A, Alimoghaddam K, Ghaffari SH. Synergistic Effects of Arsenic Trioxide and Silibinin on Apoptosis and Invasion in Human Glioblastoma U87MG Cell Line. Neurochem Res 2012;37:370-80. [DOI: 10.1007/s11064-011-0620-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
178 Toyoda-hokaiwado N, Yasui Y, Muramatsu M, Masumura K, Takamune M, Yamada M, Ohta T, Tanaka T, Nohmi T. Chemopreventive effects of silymarin against 1,2-dimethylhydrazine plus dextran sodium sulfate-induced inflammation-associated carcinogenicity and genotoxicity in the colon of gpt delta rats. Carcinogenesis 2011;32:1512-7. [DOI: 10.1093/carcin/bgr130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
179 Ramachandran PV, Yip-Schneider M, Schmidt CM. Natural and synthetic α,β-unsaturated carbonyls for NF-κB inhibition. Future Med Chem 2009;1:179-200. [PMID: 21426075 DOI: 10.4155/fmc.09.15] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
180 Theodosiou E, Loutrari H, Stamatis H, Roussos C, Kolisis FN. Biocatalytic synthesis and antitumor activities of novel silybin acylated derivatives with dicarboxylic acids. New Biotechnology 2011;28:342-8. [DOI: 10.1016/j.nbt.2011.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
181 Karkanis A, Bilalis D, Efthimiadou A. Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Industrial Crops and Products 2011;34:825-30. [DOI: 10.1016/j.indcrop.2011.03.027] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
182 Das S, Roy P, Auddy RG, Mukherjee A. Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomedicine 2011;6:1291-301. [PMID: 21753880 DOI: 10.2147/IJN.S15160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
183 Jiang YY, Huang H, Wang HJ, Wu D, Yang R, Tashiro S, Onodera S, Ikejima T. Interruption of mitochondrial complex IV activity and cytochrome c expression activated O₂·⁻-mediated cell survival in silibinin-treated human melanoma A375-S2 cells via IGF-1R-PI3K-Akt and IGF-1R-PLC γ-PKC pathways. Eur J Pharmacol 2011;668:78-87. [PMID: 21703257 DOI: 10.1016/j.ejphar.2011.06.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
184 Okano JI, Fujise Y, Abe R, Imamoto R, Murawaki Y. Chemoprevention against hepatocellular carcinoma. Clin J Gastroenterol 2011;4:185-97. [PMID: 26189518 DOI: 10.1007/s12328-011-0227-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
185 Banaee M, Sureda A, Mirvaghefi AR, Rafei GR. Effects of long-term silymarin oral supplementation on the blood biochemical profile of rainbow trout (Oncorhynchus mykiss). Fish Physiol Biochem 2011;37:885-96. [PMID: 21519846 DOI: 10.1007/s10695-011-9486-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
186 Jeong JC, Shin WY, Kim TH, Kwon CH, Kim JH, Kim YK, Kim KH. Silibinin induces apoptosis via calpain-dependent AIF nuclear translocation in U87MG human glioma cell death. J Exp Clin Cancer Res 2011;30:44. [PMID: 21501525 DOI: 10.1186/1756-9966-30-44] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
187 Zhan T, Digel M, Küch E, Stremmel W, Füllekrug J. Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins. J Cell Biochem 2011;112:849-59. [DOI: 10.1002/jcb.22984] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 6.3] [Reference Citation Analysis]
188 Malekinejad H, Taheri-broujerdi M, Moradi M, Tabatabaie S. Silymarin potentiates the antinociceptive effect of morphine in mice: SILYMARIN ANTINOCICEPTIVE EFFECT. Phytother Res 2011;25:250-5. [DOI: 10.1002/ptr.3251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
189 Dagne A, Melkamu T, Schutten MM, Qian X, Upadhyaya P, Luo X, Kassie F. Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice. Carcinogenesis 2011;32:561-7. [PMID: 21273642 DOI: 10.1093/carcin/bgr010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
190 Wang X, Gocek E, Novik V, Harrison JS, Danilenko M, Studzinski GP. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3). Cell Cycle 2010;9:4542-51. [PMID: 21084834 DOI: 10.4161/cc.9.22.13790] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
191 Ai W, Zhang Y, Tang QZ, Yan L, Bian ZY, Liu C, Huang H, Bai X, Yin L, Li H. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. J Cell Biochem 2010;110:1111-22. [PMID: 20564207 DOI: 10.1002/jcb.22623] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
192 Mata-Santos HA, Lino FG, Rocha CC, Paiva CN, Castelo Branco MT, Pyrrho Ados S. Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis. Parasitol Res 2010;107:1429-34. [PMID: 20694562 DOI: 10.1007/s00436-010-2014-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
193 Cacho M, Torres Domínguez A, Elena-rosselló J. Are polyamines directly involved in silymarin production in the milk thistle [Silybum marianum (L.) Gaernt]? Plant Cell Tiss Organ Cult 2010;103:361-8. [DOI: 10.1007/s11240-010-9789-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
194 Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res 2010;24:1423-32. [DOI: 10.1002/ptr.3207] [Cited by in Crossref: 289] [Cited by in F6Publishing: 279] [Article Influence: 24.1] [Reference Citation Analysis]
195 Wang HJ, Jiang YY, Wei XF, Huang H, Tashiro S, Onodera S, Ikejima T. Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells. Free Radic Res 2010;44:90-100. [PMID: 19968587 DOI: 10.3109/10715760903300717] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
196 Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food and Chemical Toxicology 2010;48:803-6. [DOI: 10.1016/j.fct.2009.12.011] [Cited by in Crossref: 142] [Cited by in F6Publishing: 142] [Article Influence: 11.8] [Reference Citation Analysis]
197 Schmit TL, Ledesma MC, Ahmad N. Modulating polo-like kinase 1 as a means for cancer chemoprevention. Pharm Res 2010;27:989-98. [PMID: 20107874 DOI: 10.1007/s11095-010-0051-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
198 Li L, Zeng J, Gao Y, He D. Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs 2010;19:243-55. [DOI: 10.1517/13543780903533631] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
199 Martina K, Puntambekar DS, Barge A, Gallarate M, Chirio D, Cravotto G. Synthesis, characterization and potential application of monoacyl-cyclodextrins. Carbohydrate Research 2010;345:191-8. [DOI: 10.1016/j.carres.2009.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
200 Tomankova K, Kolarova H, Kolar P, Kejlova K, Jirova D. Study of cytotoxic effect of photodynamically and sonodynamically activated sensitizers in vitro. Toxicology in Vitro 2009;23:1465-71. [DOI: 10.1016/j.tiv.2009.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
201 Sy-Cordero A, Graf TN, Nakanishi Y, Wani MC, Agarwal R, Kroll DJ, Oberlies NH. Large-scale isolation of flavonolignans from Silybum marianum extract affords new minor constituents and preliminary structure-activity relationships. Planta Med. 2010;76:644-647. [PMID: 19941262 DOI: 10.1055/s-0029-1240624] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
202 Brantley SJ, Oberlies NH, Kroll DJ, Paine MF. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations. J Pharmacol Exp Ther 2010;332:1081-7. [PMID: 19934397 DOI: 10.1124/jpet.109.161927] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
203 Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 2010;291:120-9. [PMID: 19900758 DOI: 10.1016/j.canlet.2009.10.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
204 Kim JH, Kim K, Jin HM, Song I, Youn BU, Lee J, Kim N. Silibinin inhibits osteoclast differentiation mediated by TNF family members. Mol Cells 2009;28:201-7. [DOI: 10.1007/s10059-009-0123-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
205 Fehér J, Lengyel G. Silymarin in the treatment of chronic liver diseases: Past and future. Clinical and Experimental Medical Journal 2009;3:403-13. [DOI: 10.1556/cemed.3.2009.28519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
206 Kaur G, Athar M, Alam MS. Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response. Invest New Drugs 2010;28:703-13. [PMID: 19590824 DOI: 10.1007/s10637-009-9289-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
207 Fathi-achachlouei B, Azadmard-damirchi S. Milk Thistle Seed Oil Constituents from Different Varieties Grown in Iran. J Am Oil Chem Soc 2009;86:643-9. [DOI: 10.1007/s11746-009-1399-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
208 Pan M, Lai C, Dushenkov S, Ho C. Modulation of Inflammatory Genes by Natural Dietary Bioactive Compounds. J Agric Food Chem 2009;57:4467-77. [DOI: 10.1021/jf900612n] [Cited by in Crossref: 177] [Cited by in F6Publishing: 160] [Article Influence: 13.6] [Reference Citation Analysis]
209 Kim KW, Choi CH, Kim TH, Kwon CH, Woo JS, Kim YK. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo. Neurochem Res 2009;34:1479-90. [PMID: 19263218 DOI: 10.1007/s11064-009-9935-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
210 Bode AM, Dong Z. Signal transduction molecules as targets for cancer prevention. Sci Signal 2009;2:mr2. [PMID: 19244209 DOI: 10.1126/scisignal.259mr2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
211 Khakinezhad Tehrani F, Ranji N, Kouhkan F, Hosseinzadeh S. Apoptosis induction and proliferation inhibition by silibinin encapsulated in nanoparticles in MIA PaCa-2 cancer cells and deregulation of some miRNAs. Iran J Basic Med Sci 2020;23:469-82. [PMID: 32489562 DOI: 10.22038/ijbms.2020.39427.9349] [Cited by in F6Publishing: 2] [Reference Citation Analysis]